Obstructive sleep apnea syndrome: From phenotype to genetic basis

M. Casale, M. Pappacena, V. Rinaldi, F. Bressi, P. Baptista, F. Salvinelli

Research output: Contribution to journalArticle

Abstract

Obstructive sleep apnea syndrome (OSAS) is a complex chronic clinical syndrome, characterized by snoring, periodic apnea, hypoxemia during sleep, and daytime hypersomnolence. It affects 4-5% of the general population. Racial studies and chromosomal mapping, familial studies and twin studies have provided evidence for the possible link between the OSAS and genetic factors and also most of the risk factors involved in the pathogenesis of OSAS are largely genetically determined. A percentage of 35-40% of its variance can be attributed to genetic factors. It is likely that genetic factors associated with craniofacial structure, body fat distribution and neural control of the upper airway muscles interact to produce the OSAS phenotype. Although the role of specific genes that influence the development of OSAS has not yet been identified, current researches, especially in animal model, suggest that several genetic systems may be important. In this chapter, we will first define the OSAS phenotype, the pathogenesis and the risk factors involved in the OSAS that may be inherited, then, we will review the current progress in the genetics of OSAS and suggest a few future perspectives in the development of therapeutic agents for this complex disease entity.

Original languageEnglish
Pages (from-to)119-126
Number of pages8
JournalCurrent Genomics
Volume10
Issue number2
DOIs
Publication statusPublished - 2009

Fingerprint

Obstructive Sleep Apnea
Phenotype
Disorders of Excessive Somnolence
Body Fat Distribution
Snoring
Twin Studies
Airway Management
Apnea
Sleep
Animal Models
Muscles
Research
Population
Genes

Keywords

  • AHI
  • Genetic
  • Hypopnea
  • Multifactorial disease
  • Obstructive sleep apnea
  • Phenotype
  • Risk factors
  • Snoring

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Casale, M., Pappacena, M., Rinaldi, V., Bressi, F., Baptista, P., & Salvinelli, F. (2009). Obstructive sleep apnea syndrome: From phenotype to genetic basis. Current Genomics, 10(2), 119-126. https://doi.org/10.2174/138920209787846998

Obstructive sleep apnea syndrome : From phenotype to genetic basis. / Casale, M.; Pappacena, M.; Rinaldi, V.; Bressi, F.; Baptista, P.; Salvinelli, F.

In: Current Genomics, Vol. 10, No. 2, 2009, p. 119-126.

Research output: Contribution to journalArticle

Casale, M, Pappacena, M, Rinaldi, V, Bressi, F, Baptista, P & Salvinelli, F 2009, 'Obstructive sleep apnea syndrome: From phenotype to genetic basis', Current Genomics, vol. 10, no. 2, pp. 119-126. https://doi.org/10.2174/138920209787846998
Casale M, Pappacena M, Rinaldi V, Bressi F, Baptista P, Salvinelli F. Obstructive sleep apnea syndrome: From phenotype to genetic basis. Current Genomics. 2009;10(2):119-126. https://doi.org/10.2174/138920209787846998
Casale, M. ; Pappacena, M. ; Rinaldi, V. ; Bressi, F. ; Baptista, P. ; Salvinelli, F. / Obstructive sleep apnea syndrome : From phenotype to genetic basis. In: Current Genomics. 2009 ; Vol. 10, No. 2. pp. 119-126.
@article{059d130ee9714a108e1f600069c18968,
title = "Obstructive sleep apnea syndrome: From phenotype to genetic basis",
abstract = "Obstructive sleep apnea syndrome (OSAS) is a complex chronic clinical syndrome, characterized by snoring, periodic apnea, hypoxemia during sleep, and daytime hypersomnolence. It affects 4-5{\%} of the general population. Racial studies and chromosomal mapping, familial studies and twin studies have provided evidence for the possible link between the OSAS and genetic factors and also most of the risk factors involved in the pathogenesis of OSAS are largely genetically determined. A percentage of 35-40{\%} of its variance can be attributed to genetic factors. It is likely that genetic factors associated with craniofacial structure, body fat distribution and neural control of the upper airway muscles interact to produce the OSAS phenotype. Although the role of specific genes that influence the development of OSAS has not yet been identified, current researches, especially in animal model, suggest that several genetic systems may be important. In this chapter, we will first define the OSAS phenotype, the pathogenesis and the risk factors involved in the OSAS that may be inherited, then, we will review the current progress in the genetics of OSAS and suggest a few future perspectives in the development of therapeutic agents for this complex disease entity.",
keywords = "AHI, Genetic, Hypopnea, Multifactorial disease, Obstructive sleep apnea, Phenotype, Risk factors, Snoring",
author = "M. Casale and M. Pappacena and V. Rinaldi and F. Bressi and P. Baptista and F. Salvinelli",
year = "2009",
doi = "10.2174/138920209787846998",
language = "English",
volume = "10",
pages = "119--126",
journal = "Current Genomics",
issn = "1389-2029",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Obstructive sleep apnea syndrome

T2 - From phenotype to genetic basis

AU - Casale, M.

AU - Pappacena, M.

AU - Rinaldi, V.

AU - Bressi, F.

AU - Baptista, P.

AU - Salvinelli, F.

PY - 2009

Y1 - 2009

N2 - Obstructive sleep apnea syndrome (OSAS) is a complex chronic clinical syndrome, characterized by snoring, periodic apnea, hypoxemia during sleep, and daytime hypersomnolence. It affects 4-5% of the general population. Racial studies and chromosomal mapping, familial studies and twin studies have provided evidence for the possible link between the OSAS and genetic factors and also most of the risk factors involved in the pathogenesis of OSAS are largely genetically determined. A percentage of 35-40% of its variance can be attributed to genetic factors. It is likely that genetic factors associated with craniofacial structure, body fat distribution and neural control of the upper airway muscles interact to produce the OSAS phenotype. Although the role of specific genes that influence the development of OSAS has not yet been identified, current researches, especially in animal model, suggest that several genetic systems may be important. In this chapter, we will first define the OSAS phenotype, the pathogenesis and the risk factors involved in the OSAS that may be inherited, then, we will review the current progress in the genetics of OSAS and suggest a few future perspectives in the development of therapeutic agents for this complex disease entity.

AB - Obstructive sleep apnea syndrome (OSAS) is a complex chronic clinical syndrome, characterized by snoring, periodic apnea, hypoxemia during sleep, and daytime hypersomnolence. It affects 4-5% of the general population. Racial studies and chromosomal mapping, familial studies and twin studies have provided evidence for the possible link between the OSAS and genetic factors and also most of the risk factors involved in the pathogenesis of OSAS are largely genetically determined. A percentage of 35-40% of its variance can be attributed to genetic factors. It is likely that genetic factors associated with craniofacial structure, body fat distribution and neural control of the upper airway muscles interact to produce the OSAS phenotype. Although the role of specific genes that influence the development of OSAS has not yet been identified, current researches, especially in animal model, suggest that several genetic systems may be important. In this chapter, we will first define the OSAS phenotype, the pathogenesis and the risk factors involved in the OSAS that may be inherited, then, we will review the current progress in the genetics of OSAS and suggest a few future perspectives in the development of therapeutic agents for this complex disease entity.

KW - AHI

KW - Genetic

KW - Hypopnea

KW - Multifactorial disease

KW - Obstructive sleep apnea

KW - Phenotype

KW - Risk factors

KW - Snoring

UR - http://www.scopus.com/inward/record.url?scp=65949106341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65949106341&partnerID=8YFLogxK

U2 - 10.2174/138920209787846998

DO - 10.2174/138920209787846998

M3 - Article

C2 - 19794884

AN - SCOPUS:65949106341

VL - 10

SP - 119

EP - 126

JO - Current Genomics

JF - Current Genomics

SN - 1389-2029

IS - 2

ER -